BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zhe Li, Jingyong Xu, Hongyuan Cui, Jinghai Song, Jian Chen, Junmin Wei. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virusMedicine 2020; 99(20): e20302 doi: 10.1097/MD.0000000000020302
2
Zhi-Jun Dai, Xing-Han Liu, Meng Wang, Yan Guo, Wenge Zhu, Xiao Li, Shuai Lin, Tian Tian, Kang Liu, Yi Zheng, Peng Xu, Tianbo Jin, Xiaopeng Li. IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control studyOncotarget 2017; 8(46): 81350 doi: 10.18632/oncotarget.18531
3
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinomaExpert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
4
Erwin Ho, Stijn Van Hees, Sofie Goethals, Elke Smits, Manon Huizing, Sven Francque, Benedicte De Winter, Peter Michielsen, Thomas Vanwolleghem. Biobanking for Viral Hepatitis ResearchFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00183
5
M. Rajesh Kumar, A. Manikandan, A. Sivakumar, V. Violet Dhayabaran. An eco-friendly catalytic system for multicomponent, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanismBioorganic Chemistry 2018; 81: 44 doi: 10.1016/j.bioorg.2018.07.037
6
Hongsheng Guo, Peng Li, Liudan Su, Kun Wu, Kai Huang, Ruizhi Lai, Jing Xu, Dingbao Sun, Shuxian Li, Ziliang Deng, Yan Wang, Haina Guo, Zhangquan Chen, Sen Wang. Low expression of IL-37 protein is correlated with high Oct4 protein expression in hepatocellular carcinomaGene 2020; 737: 144445 doi: 10.1016/j.gene.2020.144445
7
Maria Angeles Aller, Natalia Arias, Javier Blanco-Rivero, Gloria Balfagón, Jaime Arias. Portal hypertension: The desperate search for the placentaCurrent Research in Translational Medicine 2019; 67(2): 56 doi: 10.1016/j.retram.2018.09.001
8
Juqiang Han, Jiarui Li, Yun Qian, Wenpeng Liu, Jiguang Liang, Zhigang Huang, Shuai Wang, Caiyan Zhao. Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2019; 43(5): 585 doi: 10.1016/j.clinre.2018.12.008
9
S. Van Hees, S. Bourgeois, H. Van Vlierberghe, T. Sersté, S. Francque, P. Michielsen, D. Sprengers, H. Reynaert, J. Henrion, S. Negrin Dastis, J. Delwaide, L. Lasser, J. Decaestecker, H. Orlent, F. Janssens, G. Robaeys, I. Colle, P. Stärkel, C. Moreno, F. Nevens, T. Vanwolleghem. Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesAlimentary Pharmacology & Therapeutics 2018; 47(8): 1170 doi: 10.1111/apt.14560
10
Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinomaGenes & Diseases 2017; 4(2): 116 doi: 10.1016/j.gendis.2017.03.003
11
Angelo Fassio, Luca Idolazzi, Ombretta Viapiana, Camilla Benini, Elisabetta Vantaggiato, Francesco Bertoldo, Maurizio Rossini, Davide Gatti. In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controlsClinical Rheumatology 2017; 36(10): 2377 doi: 10.1007/s10067-017-3734-2
12
Anders Boyd, Léa Duchesne, Karine Lacombe. Research gaps in viral hepatitisJournal of the International AIDS Society 2018; 21: e25054 doi: 10.1002/jia2.25054
13
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosisWorld Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
14
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
15
Xiulan Xue, Wei Liao, Yugang Xing. Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinomaInfectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-0273-2
16
Carol Lee, Siu Tim Cheung. STAT3: An Emerging Therapeutic Target for Hepatocellular CarcinomaCancers 2019; 11(11): 1646 doi: 10.3390/cancers11111646
17
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysisScandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824